Correlation Between Dr Reddys and Intracellular

Can any of the company-specific risk be diversified away by investing in both Dr Reddys and Intracellular at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Dr Reddys and Intracellular into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Dr Reddys Laboratories and Intracellular Th, you can compare the effects of market volatilities on Dr Reddys and Intracellular and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Dr Reddys with a short position of Intracellular. Check out your portfolio center. Please also check ongoing floating volatility patterns of Dr Reddys and Intracellular.

Diversification Opportunities for Dr Reddys and Intracellular

-0.82

Correlation Coefficient

Dr Reddys  Intracellular

Pay attention - limited upside

The 3 months correlation between RDY and Intracellular is -0.82. Overlapping area represents the amount of risk that can be diversified away by holding Dr Reddys Laboratories and Intracellular Th in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Intracellular Th and Dr Reddys is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Dr Reddys Laboratories are associated (or correlated) with Intracellular. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Intracellular Th has no effect on the direction of Dr Reddys i.e., Dr Reddys and Intracellular go up and down completely randomly.

Pair Corralation between Dr Reddys and Intracellular

Considering the 90-day investment horizon Dr Reddys Laboratories is expected to under-perform the Intracellular. But the stock apears to be less risky and, when comparing its historical volatility, Dr Reddys Laboratories is 3.11 times less risky than Intracellular. The stock trades about -0.18 of its potential returns per unit of risk. The Intracellular Th is currently generating about 0.18 of returns per unit of risk over similar time horizon. If you would invest  8,348  in Intracellular Th on December 30, 2024 and sell it today you would earn a total of  4,833  from holding Intracellular Th or generate 57.89% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Dr Reddys Laboratories  vs.  Intracellular Th

Dr Reddys Laboratories

Risk-Adjusted Performance

Very Weak

Over the last 90 days Dr Reddys Laboratories has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's fundamental indicators remain fairly strong which may send shares a bit higher in April 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Intracellular Th

Risk-Adjusted Performance

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Intracellular Th are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. Despite fairly uncertain fundamental indicators, Intracellular demonstrated solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Dr Reddys and Intracellular

The main advantage of trading using opposite Dr Reddys and Intracellular positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Dr Reddys position performs unexpectedly, Intracellular can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Intracellular will offset losses from the drop in Intracellular's long position.

The idea behind Dr Reddys Laboratories and Intracellular Th pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.